These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36062666)

  • 1. Outcome of ventricular tachycardia catheter ablation in ischemic heart disease patients using a high-density mapping substrate-based approach: A prospective cohort study.
    Lima da Silva G; Cortez-Dias N; Carpinteiro L; Pinto FJ; de Sousa J
    Rev Port Cardiol; 2022 Apr; 41(4):325-335. PubMed ID: 36062666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of substrate-based ablation for ventricular tachycardia in patients with frequent appropriate implantable cardioverter-defibrillator therapy and dilated cardiomyopathy: Long-term experience with high-density mapping.
    Oliveira M; Cunha P; Valente B; Portugal G; Lousinha A; Pereira M; Braz M; Delgado A; Ferreira RC
    Rev Port Cardiol (Engl Ed); 2021 Nov; 40(11):865-873. PubMed ID: 34857160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catheter Ablation of Ischemic Ventricular Tachycardia With Remote Magnetic Navigation: STOP-VT Multicenter Trial.
    Skoda J; Arya A; Garcia F; Gerstenfeld E; Marchlinski F; Hindricks G; Miller J; Petru J; Sediva L; Sha Q; Janotka M; Chovanec M; Waldauf P; Neuzil P; Reddy VY
    J Cardiovasc Electrophysiol; 2016 Mar; 27 Suppl 1():S29-37. PubMed ID: 26969220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency catheter ablation of ventricular tachycardia in ischemic heart disease in light of current practice: a systematic review and meta-analysis of randomized controlled trials.
    Lima da Silva G; Nunes-Ferreira A; Cortez-Dias N; de Sousa J; J Pinto F; Caldeira D
    J Interv Card Electrophysiol; 2020 Dec; 59(3):603-616. PubMed ID: 32948937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Outcome of Substrate Modification in Ablation of Post-Myocardial Infarction Ventricular Tachycardia.
    Wolf M; Sacher F; Cochet H; Kitamura T; Takigawa M; Yamashita S; Vlachos K; Cheniti G; Frontera A; Martin R; Thompson N; Massoullié G; Lam A; Martin C; Collot F; Duchateau J; Pambrun T; Denis A; Derval N; Hocini M; Haïssaguerre M; Jaïs P
    Circ Arrhythm Electrophysiol; 2018 Feb; 11(2):e005635. PubMed ID: 29440186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease.
    Martinez BK; Baker WL; Konopka A; Giannelli D; Coleman CI; Kluger J; Cronin EM
    Heart Rhythm; 2020 Jan; 17(1):e206-e219. PubMed ID: 31082362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of early catheter ablation for ventricular tachycardia in adult patients with structural heart disease and implantable cardioverter-defibrillator: An updated systematic review and meta-analysis of randomized trials.
    Shalganov T; Stoyanov M; Traykov V
    Front Cardiovasc Med; 2022; 9():1063147. PubMed ID: 36531738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): A Multicenter Randomized Trial.
    Willems S; Tilz RR; Steven D; Kääb S; Wegscheider K; Gellér L; Meyer C; Heeger CH; Metzner A; Sinner MF; Schlüter M; Nordbeck P; Eckardt L; Bogossian H; Sultan A; Wenzel B; Kuck KH;
    Circulation; 2020 Mar; 141(13):1057-1067. PubMed ID: 32000514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive versus deferred catheter ablation of myocardial infarct-associated ventricular tachycardia: A meta-analysis.
    Kampaktsis PN; Doulamis IP; Tzani A; Cheung JW
    Heart Rhythm O2; 2020 Oct; 1(4):275-282. PubMed ID: 34113881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Substrate-Based Ablation of Ventricular Tachycardia on Cardiac Mortality in Patients With Implantable Cardioverter-Defibrillators.
    Komatsu Y; Maury P; Sacher F; Khairy P; Daly M; Lim HS; Zellerhoff S; Jesel L; Rollin A; Duparc A; Mondoly P; Aurillac-Lavignolle V; Shah A; Denis A; Cochet H; Derval N; Hocini M; Haïssaguerre M; Jaïs P
    J Cardiovasc Electrophysiol; 2015 Nov; 26(11):1230-1238. PubMed ID: 26332030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-density substrate-guided ventricular tachycardia ablation: role of activation mapping in an attempt to improve procedural effectiveness.
    Carbucicchio C; Ahmad Raja N; Di Biase L; Volpe V; Dello Russo A; Trivedi C; Bartoletti S; Zucchetti M; Casella M; Russo E; Santangeli P; Moltrasio M; Tundo F; Fassini G; Natale A; Tondo C
    Heart Rhythm; 2013 Dec; 10(12):1850-8. PubMed ID: 24055940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term benefit of first-line peri-implantable cardioverter-defibrillator implant ventricular tachycardia-substrate ablation in secondary prevention patients.
    Acosta J; Cabanelas N; Penela D; Fernández-Armenta J; Andreu D; Borràs R; Korshunov V; Cabrera M; Vasanelli F; Arbelo E; Guasch E; Martínez M; Tolosana JM; Mont L; Berruezo A
    Europace; 2017 Jun; 19(6):976-982. PubMed ID: 27353322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only.
    Bunch TJ; Weiss JP; Crandall BG; Day JD; May HT; Bair TL; Osborn JS; Mallender C; Fischer A; Brunner KJ; Mahapatra S
    Heart Rhythm; 2014 Apr; 11(4):533-40. PubMed ID: 24333283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia.
    Jaïs P; Maury P; Khairy P; Sacher F; Nault I; Komatsu Y; Hocini M; Forclaz A; Jadidi AS; Weerasooryia R; Shah A; Derval N; Cochet H; Knecht S; Miyazaki S; Linton N; Rivard L; Wright M; Wilton SB; Scherr D; Pascale P; Roten L; Pederson M; Bordachar P; Laurent F; Kim SJ; Ritter P; Clementy J; Haïssaguerre M
    Circulation; 2012 May; 125(18):2184-96. PubMed ID: 22492578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthogonal high-density mapping with ventricular tachycardia isthmus analysis vs. pure substrate ventricular tachycardia ablation: A case-control study.
    Vázquez-Calvo S; Garre P; Sanchez-Somonte P; Borras R; Quinto L; Caixal G; Pujol-Lopez M; Althoff T; Guasch E; Arbelo E; Tolosana JM; Brugada J; Mont L; Roca-Luque I
    Front Cardiovasc Med; 2022; 9():912335. PubMed ID: 35979023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy.
    Gandjbakhch E; Laredo M; Berruezo A; Gourraud JB; Sellal JM; Martins R; Sacher F; Pison L; Pruvot E; Jáuregui B; Frontera A; Kumar S; Wong T; DellaBella P; Maury P
    Europace; 2021 Sep; 23(9):1428-1436. PubMed ID: 34427302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate-modification using electroanatomical mapping in sinus rhythm to treat ventricular tachycardia in patients with ischemic cardiomyopathy.
    Deneke T; Grewe PH; Lawo T; Calcum B; Mügge A; Lemke B
    Z Kardiol; 2005 Jul; 94(7):453-60. PubMed ID: 15997346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular tachycardia burden reduction after substrate ablation: Predictors of recurrence.
    Quinto L; Sanchez-Somonte P; Alarcón F; Garre P; Castillo À; San Antonio R; Borras R; Guasch E; Arbelo E; Tolosana JM; Berruezo A; Mont L; Roca-Luque I
    Heart Rhythm; 2021 Jun; 18(6):896-904. PubMed ID: 33639298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy: A Multicenter International Ventricular Tachycardia Registry.
    Santangeli P; Tung R; Xue Y; Chung FP; Lin YJ; Di Biase L; Zhan X; Lin CY; Wei W; Mohanty S; Burkhardt DJ; Zado ES; Callans DJ; Marchlinski FE; Wu S; Chen SA; Natale A
    JACC Clin Electrophysiol; 2019 Jan; 5(1):55-65. PubMed ID: 30678787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.